The Motley Fool

Aviva’s share price falls 40%. Here’s why I’d still invest with dividends suspended

On Wednesday, Aviva’s (LSE: AV) share price took another tumble as the UK insurers scrapped plans to pay dividends.

The announcement rubs further salt in the wounds of income investors, who have already been hurt by the UK banks agreeing to cease dividend pay-outs.

Claim your FREE copy of The Motley Fool’s Bear Market Survival Guide.

Global stock markets may be reeling from the coronavirus, but you don’t have to face this down market alone. Help yourself to a FREE copy of The Motley Fool’s Bear Market Survival Guide and discover the five steps you can take right now to try and bolster your portfolio… including how you can aim to turn today’s market uncertainty to your advantage. Click here to claim your FREE copy now!

According to The Financial Times, British insurance companies RSA, Direct Line, and Hiscox have all agreed to suspend dividends alongside Aviva. This comes after pressure from the Bank of England in light of the impact of coronavirus on the economy. Only Legal & General confirmed it would push ahead with its pay-out.

So, with a falling share price and a suspension of dividends, things don’t look too good on the surface for Aviva. But here’s why I’d still invest in the FTSE 100 insurance stalwart.

Great value

First and foremost, I think Aviva’s current share price is great value. Since mid-February, it has shaved around 40% from its valuation. That’s substantially more than the near 25% drop in the value of the FTSE 100 index.

While a huge price drop doesn’t automatically entail good value, I don’t think this is the case for Aviva.

Shares are now trading on a price-to-earnings ratio of just 4.18, which to me indicates that the stock may be undervalued.

Remember that for that price, you’re getting a position in the UK’s largest general insurer. On top of this, Aviva is a market-leading pensions provider, with around 33 million customers across 16 different countries.

Ultimately, Aviva is a blue-chip insurance giant that won’t go under easily.

Strong financial position

For me, Aviva’s strong financial position only strengthens the case. In early March, the company posted record full-year profits, underscoring a successful year in 2019.

Although results will undoubtedly be weaker this year, the company maintains a strong balance sheet with healthy cash flows that should dampen the impact on earnings.

What’s more, the group has recently taken action to further reinforce its liquidity position.

As a result of suspending dividend payments, the company states it remains “well capitalised with strong liquidity”.

By scrapping the final dividend, Aviva estimates its group capital ratio will increase by around 7% to approximately 182%. That’s a healthy ratio, even in times of crisis, in my eyes.

A bright future for Aviva

Although it remains too early to determine the full impact of the coronavirus outbreak on business, I’m confident Aviva can weather the financial storm.

If so, investors can expect to be rewarded twofold as Aviva’s share price recovers and dividend payments start up again.

The company is known for its attractive dividend yield, which sat at 7.40% at the end of 2019. What’s more, Aviva successfully increased its dividend for the last six years.

With that in mind, Aviva’s share price looks like a bargain to me. Investors willing to stick with the group over the long term can expect the company to come out the other side in good shape.

There’s a ‘double agent’ hiding in the FTSE… we recommend you buy it!

Don’t miss our special stock presentation.

It contains details of a UK-listed company our Motley Fool UK analysts are extremely enthusiastic about.

They think it’s offering an incredible opportunity to grow your wealth over the long term – at its current price – regardless of what happens in the wider market.

That’s why they’re referring to it as the FTSE’s ‘double agent’.

Because they believe it’s working both with the market… And against it.

To find out why we think you should add it to your portfolio today…

Click here to read our presentation.

Matthew Dumigan has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.